Summit Global Investments’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
Summit Global Investments's RGEN Position: Q4 2021 in Review
Summit Global Investments sold out of Repligen (RGEN) in Q4 2021, closing a stake of 3,000 shares — an estimated $867K sold.
Summit Global Investments first reported a position in RGEN in Q2 2020 and held it in 6 quarters. The position peaked at $2.64M in Q4 2020. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.
- Summit Global Investments reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
- Summit Global Investments sold 3,000 Repligen shares in Q4 2021, an estimated $867K.
- Summit Global Investments first reported a position in Repligen in Q2 2020 and held it in 6 quarters.
- Summit Global Investments's Repligen position peaked at $2.64M in Q4 2020.
- 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.
Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.